Maternal RSV Vaccination 102
Show notes In this week's episode of the SMFM podcast, Dr. Kecia Gaither and Dr. Neil Silverman discuss maternal RSV vaccination and the Pfizer Abrysvo vaccine. Learn about the latest updates for the 2024-2025 respiratory season, how to counsel patients effectively, and strategies to ensure vaccine access. The conversation also covers addressing vaccine hesitancy, navigating barriers like cost and availability, and comparing maternal vaccination with neonatal immunization options to protect infants from severe RSV infections Resources SMFM Podcast: Maternal RSV Vaccination 101 smfm.org/RSV Full transcript can be found here. Disclaimer: Sponsored by a grant from Pfizer, Inc. No content should be considered a solicitation, promotion, or advertisement for any Pfizer product. Addendum for the 2026-2027 respiratory disease season: The recommendation timing for the maternal RSV vaccine is from September 1st through March 1st, rather than through January 31st, to accommodate the anticipated longer RSV season, as observed during the 2025-2026 season.
Embed this episode
No transcript yet.